10-Q Filing

ELI LILLY & CO CIK: 59478 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000059478-21-000171`
Period End Date	20210630
Filing Date	20210803
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	lly-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 60 Cash Flow Statement 66 Stockholders Equity 17 Comprehensive Income 10

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Allowances for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$23.90M	USD	Point-in-time
Allowances for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$25.90M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$9.84B	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$9.57B	USD	Point-in-time
Cash and cash equivalents (Note 6)	`CashAndCashEquivalentsAtCarryingValue`	$3.66B	USD	Point-in-time
Cash and cash equivalents (Note 6)	`CashAndCashEquivalentsAtCarryingValue`	$3.22B	USD	Point-in-time
Short-term investments (Note 6)	`ShortTermInvestments`	$51.20M	USD	Point-in-time
Short-term investments (Note 6)	`ShortTermInvestments`	$24.20M	USD	Point-in-time
Accounts receivable, net of allowances of $23.9 (2021) and $25.9 (2020)	`AccountsReceivableNetCurrent`	$5.88B	USD	Point-in-time
Accounts receivable, net of allowances of $23.9 (2021) and $25.9 (2020)	`AccountsReceivableNetCurrent`	$5.83B	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.05B	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.07B	USD	Point-in-time
Inventories	`InventoryNet`	$3.82B	USD	Point-in-time
Inventories	`InventoryNet`	$3.98B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$2.87B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$3.30B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.46B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.30B	USD	Point-in-time
Investments (Note 6)	`LongTermInvestments`	$3.47B	USD	Point-in-time
Investments (Note 6)	`LongTermInvestments`	$2.97B	USD	Point-in-time
Goodwill	`Goodwill`	$3.88B	USD	Point-in-time
Goodwill	`Goodwill`	$3.77B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$7.45B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$7.99B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$2.67B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$2.83B	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $9,842.2 (2021) and $9,570.7 (2020)	`PropertyPlantAndEquipmentNet`	$8.68B	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $9,842.2 (2021) and $9,570.7 (2020)	`PropertyPlantAndEquipmentNet`	$8.86B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$3.48B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$3.64B	USD	Point-in-time
Total assets	`Assets`	$46.63B	USD	Point-in-time
Total assets	`Assets`	$47.81B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$8.70M	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$1.78B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.61B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.60B	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$755.50M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$997.20M	USD	Point-in-time
Sales rebates and discounts	`SalesRebatesAndDiscounts`	$5.85B	USD	Point-in-time
Sales rebates and discounts	`SalesRebatesAndDiscounts`	$7.04B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$770.80M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$770.60M	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$495.10M	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$529.90M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.62B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.75B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.09B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.48B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$14.74B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$16.59B	USD	Point-in-time
Accrued retirement benefits (Note 8)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$4.09B	USD	Point-in-time
Accrued retirement benefits (Note 8)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$3.92B	USD	Point-in-time
Long-term income taxes payable	`AccruedIncomeTaxesNoncurrent`	$3.74B	USD	Point-in-time
Long-term income taxes payable	`AccruedIncomeTaxesNoncurrent`	$3.84B	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$2.10B	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.86B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.80B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.71B	USD	Point-in-time
Total other liabilities	`LiabilitiesNoncurrent`	$28.33B	USD	Point-in-time
Total other liabilities	`LiabilitiesNoncurrent`	$26.05B	USD	Point-in-time
Commitments and Contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$598.20M	USD	Point-in-time
Common stock	`CommonStockValue`	$598.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.78B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.67B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$7.83B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$8.53B	USD	Point-in-time
Employee benefit trust	`CommonStockSharesHeldInEmployeeTrust`	$3.01B	USD	Point-in-time
Employee benefit trust	`CommonStockSharesHeldInEmployeeTrust`	$3.01B	USD	Point-in-time
Accumulated other comprehensive loss (Note 10)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.29B	USD	Point-in-time
Accumulated other comprehensive loss (Note 10)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.50B	USD	Point-in-time
Cost of common stock in treasury	`TreasuryStockValue`	$55.70M	USD	Point-in-time
Cost of common stock in treasury	`TreasuryStockValue`	$52.70M	USD	Point-in-time
Total Eli Lilly and Company shareholders equity	`StockholdersEquity`	$5.64B	USD	Point-in-time
Total Eli Lilly and Company shareholders equity	`StockholdersEquity`	$6.44B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$183.60M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$219.10M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.83B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.66B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$47.81B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$46.63B	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Revenue (Note 2)	`Revenues`	$5.50B	USD	1 Quarter
Revenue (Note 2)	`Revenues`	$13.55B	USD	2 Qtrs
Revenue (Note 2)	`Revenues`	$11.36B	USD	2 Qtrs
Revenue (Note 2)	`Revenues`	$6.74B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.22B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.44B	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$3.83B	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.95B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.78B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.39B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.67B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.36B	USD	2 Qtrs
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$3.00B	USD	2 Qtrs
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.45B	USD	1 Quarter
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$3.26B	USD	2 Qtrs
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.69B	USD	1 Quarter
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$324.30M	USD	2 Qtrs
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$241.80M	USD	1 Quarter
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$294.10M	USD	2 Qtrs
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$25.00M	USD	1 Quarter
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$59.90M	USD	2 Qtrs
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	-	USD	1 Quarter
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	-	USD	1 Quarter
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$211.60M	USD	2 Qtrs
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$446.90M	USD	1 Quarter
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$190.50M	USD	1 Quarter
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$536.00M	USD	2 Qtrs
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$511.60M	USD	2 Qtrs
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$3.86B	USD	1 Quarter
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$5.15B	USD	1 Quarter
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$10.48B	USD	2 Qtrs
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$8.04B	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.32B	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.59B	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.64B	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.07B	USD	2 Qtrs
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$203.70M	USD	1 Quarter
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$455.10M	USD	2 Qtrs
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$324.80M	USD	2 Qtrs
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$231.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.39B	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.41B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.87B	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.75B	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.16	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.56	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.53	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.02	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.15	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.01	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.55	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.53	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	907.30M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	907.20M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	907.70M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	908.20M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	910.40M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	911.60M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	910.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	911.60M	shares	2 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$1.39B	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.41B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.87B	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.75B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$719.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$598.00M	USD	2 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$413.80M	USD	2 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$93.50M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$148.60M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$177.40M	USD	2 Qtrs
Net investment gains	`GainLossOnInvestments`	$765.00M	USD	2 Qtrs
Net investment gains	`GainLossOnInvestments`	$518.10M	USD	2 Qtrs
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$324.30M	USD	2 Qtrs
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$241.80M	USD	1 Quarter
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$294.10M	USD	2 Qtrs
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$25.00M	USD	1 Quarter
Other changes in operating assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-118.40M	USD	2 Qtrs
Other changes in operating assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOtherOperatingCapitalNet`	$481.60M	USD	2 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$308.70M	USD	2 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$319.60M	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$2.88B	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$3.47B	USD	2 Qtrs
Net purchases of property and equipment	`PaymentsToAcquireProductiveAssets`	$540.10M	USD	2 Qtrs
Net purchases of property and equipment	`PaymentsToAcquireProductiveAssets`	$681.60M	USD	2 Qtrs
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$21.30M	USD	2 Qtrs
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$111.20M	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	-	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$26.60M	USD	2 Qtrs
Proceeds from sales of noncurrent investments	`ProceedsFromSaleOfLongtermInvestments`	$461.90M	USD	2 Qtrs
Proceeds from sales of noncurrent investments	`ProceedsFromSaleOfLongtermInvestments`	$412.00M	USD	2 Qtrs
Purchases of noncurrent investments	`PaymentsToAcquireLongtermInvestments`	$503.10M	USD	2 Qtrs
Purchases of noncurrent investments	`PaymentsToAcquireLongtermInvestments`	$154.80M	USD	2 Qtrs
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$747.40M	USD	2 Qtrs
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$849.30M	USD	2 Qtrs
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$254.40M	USD	2 Qtrs
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$341.80M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-50.50M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-4.10M	USD	2 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.27B	USD	2 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.77B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.35B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.54B	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromShortTermDebt`	$196.30M	USD	2 Qtrs
Net change in short-term borrowings	`RepaymentsOfShortTermDebt`	$235.40M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$988.60M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$276.30M	USD	2 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	2 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-294.80M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-197.90M	USD	2 Qtrs
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.57B	USD	2 Qtrs
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.14B	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-12.40M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.60M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$27.60M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-437.10M	USD	2 Qtrs
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.22B	USD	Point-in-time
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.66B	USD	Point-in-time
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.37B	USD	Point-in-time
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.34B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.22B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.66B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.37B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.34B	USD	Point-in-time

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.74	USD	2 Qtrs
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.74	USD	1 Quarter
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.70	USD	2 Qtrs
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.70	USD	1 Quarter
Stock repurchase program, remaining authorized amount	`StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1`	$500.00M	USD	Point-in-time
Stock repurchase program, authorized amount	`StockRepurchaseProgramAuthorizedAmount1`	$5.00B	USD	Point-in-time
Stock repurchase program, authorized amount	`StockRepurchaseProgramAuthorizedAmount1`	$8.00B	USD	Point-in-time
Purchase of treasury shares (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	1 Quarter
Purchase of treasury shares (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	2 Qtrs
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.83B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.66B	USD	Point-in-time
Net income	`ProfitLoss`	$2.75B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.87B	USD	2 Qtrs
Purchase of treasury shares (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	1 Quarter
Purchase of treasury shares (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	2 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.83B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.66B	USD	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.75B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.87B	USD	2 Qtrs
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$209.30M	USD	2 Qtrs
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$108.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$-159.30M	USD	2 Qtrs
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$203.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$1.61B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$1.50B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.95B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.71B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.